Optison (perflutren protein-A microsphr)
Intravenous Vial (ML)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: perflutren protein-A microsphr
Therapeutic class: Diagnostic Agents
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Optison
Indications
The following indications are listed for Optison:
- Diagnostic Imaging
Also known as: Diagnostic Imaging Exam, Diagnostic Imaging Procedure, Diagnostic Radiography, Diagnostic Radiology.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
| Drug label | Dosing type | Instructions |
|---|---|---|
| Optison Vial | Maintenance | Inject 0.5 milliliter by intravenous route at a rate not to exceed 1 mL per second. |
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
- Acute coronary syndrome
- Acute decompensated heart failure
- Acute myocardial infarction
- Bidirectional cardiovascular shunt
- Congenital heart disease
- Pulmonary hypertension
- Right-to-left cardiovascular shunt
- Ventricular arrhythmias
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
Less Frequent
- Chest pain
- Dyspnea
- Hypertension
- Hypoxia
- Ventricular arrhythmias
Rare or Very Rare
- Acute respiratory failure
- Anaphylaxis
- Angioedema
- Bronchospastic pulmonary disease
- Cardiac arrest
- Cardiac arrhythmia
- Edema
- Hypotension
- Myocardial ischemia
- Seizure disorder
- Shock
- Skin rash
- Throat constriction
- Unconsciousness
- Urticaria
- Wheezing
More Frequent
- Flushing
- Headache disorder
- Nausea
- Sensation of warmth
- Vomiting
Less Frequent
- Chills
- Dizziness
- Dysgeusia
- Fatigue
- Fever
- Flu-like symptoms
- General weakness
- Injection site sequelae
- Malaise
Rare or Very Rare
- Arthralgia
- Back pain
- Blurred vision
- Cough
- Eosinophilia
- Erythema
- Hypoesthesia
- Irritability
- Myalgia
- Ocular discomfort
- Palpitations
- Paresthesia
- Photophobia
- Pruritus of skin
- Tinnitus
- Tremor
- Visual changes
- Xerostomia
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.